2022
DOI: 10.1182/blood.2022017518
|View full text |Cite
|
Sign up to set email alerts
|

Differential diagnosis of bone marrow failure syndromes guided by machine learning

Abstract: The choice to postpone treatment while awaiting genetic testing can result in significant delay in definitive therapies in severely pancytopenic patients. Conversely, inherited bone marrow failure (BMF) misdiagnosis can expose patients to ineffectual and expensive therapies, toxic transplant conditioning regimens, and inappropriate use of an affected family member as a stem cell donor. To predict the likelihood of patients having acquired or inherited BMF, we developed a two-step data-driven machine-learning m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 26 publications
0
6
0
Order By: Relevance
“…However, based on recently published data about the predictive value of TL screening for the identification of inherited BMFS, 2 , 46 we feel we can confirm this approach to be justified both in terms of the underlying biology of TBD but also regarding a rational cost-benefit ratio. 47 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, based on recently published data about the predictive value of TL screening for the identification of inherited BMFS, 2 , 46 we feel we can confirm this approach to be justified both in terms of the underlying biology of TBD but also regarding a rational cost-benefit ratio. 47 …”
Section: Discussionmentioning
confidence: 99%
“…However, based on recently published data about the predictive value of TL screening for the identification of inherited BMFS, 2,46 we feel we can confirm this approach to be justified both in terms of the underlying biology of TBD but also regarding a rational cost-benefit ratio. 47 Particular strength of our study resides in its prospective real-life, multicenter character, the screening by using the validated gold standard for TL determination, namely flow-FISH, and the implementation of the extended screening, which led to the identification of another 7 VUS in TBD-associated genes, although their clinical relevance needs to be further evaluated.…”
Section: Aq7mentioning
confidence: 99%
“…For patients up to 40 years old, diepoxybutane (DEB) testing is advised to exclude Fanconi anemia. Additionally, measuring telomere length is useful for identifying those at increased risk of genetic defects in the telomerase gene complex [10]. There is growing evidence that unsuspected germline mutations not classically associated with inherited forms of marrow failure forms could underlie AA pathogenesis, almost exclusively in younger patients [9,11,12].…”
Section: Aplastic Anemia As An Immune Disordermentioning
confidence: 99%
“…20 Exciting progress with machine learning algorithms may be changing the ability to quickly determine the likelihood that presenting cytopenia is related to bone marrow failure syndromes. Gutierrez-Rodrigues et al 21 recently presented findings that a machine learning algorithm could accurately predict whether bone marrow failure syndromes were of immune (79%) or acquired (92%) etiologies in a validation cohort of 127 patients. Previously, Nazha et al 22 also proposed a personalized model to predict leukemia transformation and survival in MDS patients.…”
Section: Disease Risk Stratificationmentioning
confidence: 99%